99mtc-dtpa
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2017 (NCT02994472)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
Unclear radiopharmaceutical
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 99mtc-dtpa
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07053696 | Phase 1 | Mar 17, 2025 | University of Northern Iowa |
| NCT03031093 | N/A | Jun 1, 2017 | Federal University of Pernambuco, Universidade Federal do Rio Grande do Norte |
| NCT02994472 | N/A | Jan 1, 2017 | University of Birmingham |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Federal University of Pernambuco | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Universidade Federal do Rio Grande do Norte | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of Birmingham | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of Northern Iowa | Academic/Hospital | 1 | 1 | 1 | 2025 |
4 organizations
Page 1 / 1